Your browser doesn't support javascript.
loading
Adjuvant capecitabine for early triple-negative breast cancer: A meta-analysis of randomized controlled trials.
Liu, Mei; Fang, Huiying; Qian, Shengqiang.
Affiliation
  • Liu M; Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, 400030, China.
  • Fang H; Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, 400030, China.
  • Qian S; Department of Urology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, 400000, China. Electronic address: shengqiangqian@163.com.
Asian J Surg ; 45(9): 1748-1750, 2022 09.
Article in En | MEDLINE | ID: mdl-35168861
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Clinical_trials / Systematic_reviews Limits: Female / Humans Language: En Journal: Asian J Surg Year: 2022 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Clinical_trials / Systematic_reviews Limits: Female / Humans Language: En Journal: Asian J Surg Year: 2022 Document type: Article Affiliation country: China